Research Programs

INNODERM (687866) 2016-2021

clinical need (see 1.4.1e). INNODERM is based on market and clinical-need findings from an ERC proof of
concept study on optoacoustic imaging (see 1.5).

INNODERM is an EU funded project that brings together the expertise of Small and Medium Size Enterprises (SMEs) (iTheraRayfos, Sonaxisand academic partners (TUMHUNIMEDin the fields of photonic and ultrasound technologies. The goal of INNODERM has been to develop a novel Raster-Scan Optoacoustic Mesoscopy (RSOM) device to improve non-invasive diagnostics for skin cancer and other dermaological conditions Plus...

ESOTRAC (687866) 2017-2021

ESOTRAC aims to shift the paradigm in esophageal cancer in-vivo diagnosis and staging, by replacing two-dimensional qualitative and user dependent WLE observations of the esophageal wall with  objective, quantitative, three-dimensional measurements of the entire esophagus wall, delivering  morphological and pathophysiological cancer and pre-cancer features not available to currently used white light endoscopy. The proposal aims to achieve earlier EC diagnosis, thus saving lives and reducing healthcare costs (€3-5 Billion annual savings), by researching a revolutionary photonic endoscopy based on a hybrid multi-spectral optoacoustic tomography (MSOT) and optical coherence tomography (OCT) scope.

Plus...

WINTHER ( ) 2020-2025

The main objectives of the WINTHER project are to develop the functionality necessary to assess endothelial function with a next-generation of optoacoustic technology for achieving fast RSOM (F-RSOM). Using the skin as a window for disease assessment aided by modern computational algorithms and artificial intelligence, WINTHER aims to improve the clinical accuracy of RSOM and shift the paradigm in therapeutic monitoring of cardio-metabolic diseases and inflammatory skin conditions, strengthening Europe’s leadership in photonics and in personalized medicine. The project is driven iThera Medical with a strong history of commercializing optoacoustics for clinical applications, by leading physicians (TUMHUNIMED), and by RSOM, RSOM components and data analysis experts (TUMiTheraRayfos, Sonaxis).

Plus...

RSENSE ( ) 2020-2025

Nunc sapien mauris, imperdiet ac pellentesque quis, facilisis non sapien. Maecenas congue vehicula mi, id luctus mi scelerisque nec. Cras viverra libero ut velit ullamcorper volutpat. Maecenas ut dolor eget ante interdum auctor quis sed nunc. Proin faucibus, mauris vitae molestie sodales, erat nisi rhoncus justo, in placerat turpis elit sed eros. Mauris molestie, justo et feugiat rutrum, arcu metus dapibus quam, sollicitudin tempus tortor dolor et nibh.

Plus...

Co-Pilot () 2014-2018

Nunc sapien mauris, imperdiet ac pellentesque quis, facilisis non sapien. Maecenas congue vehicula mi, id luctus mi scelerisque nec. Cras viverra libero ut velit ullamcorper volutpat. Maecenas ut dolor eget ante interdum auctor quis sed nunc. Proin faucibus, mauris vitae molestie sodales, erat nisi rhoncus justo, in placerat turpis elit sed eros. Mauris molestie, justo et feugiat rutrum, arcu metus dapibus quam, sollicitudin tempus tortor dolor et nibh.

Plus...